Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma
BackgroundMetabolic reprogramming within the tumor microenvironment plays a pivotal role in tumor progression and therapeutic responses. Nevertheless, the relationship between aberrant glutathione (GSH) metabolism and the immune microenvironment in lung adenocarcinoma, as well as its clinical implic...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1608407/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849426918555779072 |
|---|---|
| author | Yuxiang Chi Yuxiang Chi Guoyuan Ma Qiang Liu Qiang Liu Yunzhi Xiang Yunzhi Xiang Defeng Liu Jiajun Du Jiajun Du |
| author_facet | Yuxiang Chi Yuxiang Chi Guoyuan Ma Qiang Liu Qiang Liu Yunzhi Xiang Yunzhi Xiang Defeng Liu Jiajun Du Jiajun Du |
| author_sort | Yuxiang Chi |
| collection | DOAJ |
| description | BackgroundMetabolic reprogramming within the tumor microenvironment plays a pivotal role in tumor progression and therapeutic responses. Nevertheless, the relationship between aberrant glutathione (GSH) metabolism and the immune microenvironment in lung adenocarcinoma, as well as its clinical implications, remains unclear.MethodsWe leveraged genome-wide association study (GWAS) data and applied genetic causal analysis to evaluate the causal relationships among plasma 5-oxoproline levels, lung adenocarcinoma (LUAD) risk, and 731 immune phenotypes. We incorporated single-cell RNA sequencing data from LUAD to compare transcription factor activity, cell communication networks, and CD8+ T cell subset distributions across distinct GSH metabolic groups, followed by pseudotime analysis. Whole-transcriptome data from the TCGA database were analyzed for functional enrichment, immune infiltration, and immune functionality. Prognostic genes were identified using WGCNA and LASSO-Cox regression, and the expression was validated via qRT-PCR. Thereafter, immunotherapeutic efficacy and drug sensitivity were predicted using the TIDE platform and the oncoPredict package. A prognostic model was constructed to forecast patient survival, which was further validated in two independent GEO datasets.ResultsGenetic causal analysis indicated a positive correlation between plasma 5-oxoproline levels and LUAD risk. ScRNA-seq analysis revealed an increased proportion of exhausted CD8+ T cells in the high GSH metabolic group, accompanied by altered transcription factor activity and distinct cell communication patterns. Furthermore, whole-transcriptome data analysis demonstrated that patients with a high metabolic phenotype exhibited significantly diminished immune functionality and overall immune infiltration. Using WGCNA and LASSO-Cox regression, we ultimately identified three key genes (LCAL1, RHOV, and MARCHF4) and generated a gene risk score. This score effectively predicts both immunotherapy response and drug sensitivity. qRT-PCR confirmed the upregulation of MARCHF4 in LUAD cells. In addition, stratification by gene risk scores revealed significant differences in immune cell infiltration, immunotherapeutic response, and drug sensitivity. The nomogram model demonstrated strong predictive accuracy in both the TCGA cohort and two independent GEO validation datasets.ConclusionsGSH metabolic reprogramming may suppress antitumor immunity by modulating transcription factor activity, remodeling cell communication networks, and regulating CD8+ T cells. The prognostic risk model developed herein effectively predicts immunotherapeutic response, drug sensitivity, and overall survival in patients with LUAD. |
| format | Article |
| id | doaj-art-bb9fe59846394323b7ca54e59933a01e |
| institution | Kabale University |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-bb9fe59846394323b7ca54e59933a01e2025-08-20T03:29:11ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16084071608407Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinomaYuxiang Chi0Yuxiang Chi1Guoyuan Ma2Qiang Liu3Qiang Liu4Yunzhi Xiang5Yunzhi Xiang6Defeng Liu7Jiajun Du8Jiajun Du9Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, ChinaCheeloo College of Medicine, Shandong University, Jinan, Shandong, ChinaDepartment of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaInstitute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, ChinaCheeloo College of Medicine, Shandong University, Jinan, Shandong, ChinaInstitute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, ChinaCheeloo College of Medicine, Shandong University, Jinan, Shandong, ChinaCheeloo College of Medicine, Shandong University, Jinan, Shandong, ChinaInstitute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, ChinaDepartment of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, ChinaBackgroundMetabolic reprogramming within the tumor microenvironment plays a pivotal role in tumor progression and therapeutic responses. Nevertheless, the relationship between aberrant glutathione (GSH) metabolism and the immune microenvironment in lung adenocarcinoma, as well as its clinical implications, remains unclear.MethodsWe leveraged genome-wide association study (GWAS) data and applied genetic causal analysis to evaluate the causal relationships among plasma 5-oxoproline levels, lung adenocarcinoma (LUAD) risk, and 731 immune phenotypes. We incorporated single-cell RNA sequencing data from LUAD to compare transcription factor activity, cell communication networks, and CD8+ T cell subset distributions across distinct GSH metabolic groups, followed by pseudotime analysis. Whole-transcriptome data from the TCGA database were analyzed for functional enrichment, immune infiltration, and immune functionality. Prognostic genes were identified using WGCNA and LASSO-Cox regression, and the expression was validated via qRT-PCR. Thereafter, immunotherapeutic efficacy and drug sensitivity were predicted using the TIDE platform and the oncoPredict package. A prognostic model was constructed to forecast patient survival, which was further validated in two independent GEO datasets.ResultsGenetic causal analysis indicated a positive correlation between plasma 5-oxoproline levels and LUAD risk. ScRNA-seq analysis revealed an increased proportion of exhausted CD8+ T cells in the high GSH metabolic group, accompanied by altered transcription factor activity and distinct cell communication patterns. Furthermore, whole-transcriptome data analysis demonstrated that patients with a high metabolic phenotype exhibited significantly diminished immune functionality and overall immune infiltration. Using WGCNA and LASSO-Cox regression, we ultimately identified three key genes (LCAL1, RHOV, and MARCHF4) and generated a gene risk score. This score effectively predicts both immunotherapy response and drug sensitivity. qRT-PCR confirmed the upregulation of MARCHF4 in LUAD cells. In addition, stratification by gene risk scores revealed significant differences in immune cell infiltration, immunotherapeutic response, and drug sensitivity. The nomogram model demonstrated strong predictive accuracy in both the TCGA cohort and two independent GEO validation datasets.ConclusionsGSH metabolic reprogramming may suppress antitumor immunity by modulating transcription factor activity, remodeling cell communication networks, and regulating CD8+ T cells. The prognostic risk model developed herein effectively predicts immunotherapeutic response, drug sensitivity, and overall survival in patients with LUAD.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1608407/fullmulti-omicssingle-cell sequencingglutathione metabolismimmunotherapyprognostic model |
| spellingShingle | Yuxiang Chi Yuxiang Chi Guoyuan Ma Qiang Liu Qiang Liu Yunzhi Xiang Yunzhi Xiang Defeng Liu Jiajun Du Jiajun Du Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma Frontiers in Immunology multi-omics single-cell sequencing glutathione metabolism immunotherapy prognostic model |
| title | Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma |
| title_full | Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma |
| title_fullStr | Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma |
| title_full_unstemmed | Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma |
| title_short | Multi-omics analysis reveals glutathione metabolism-related immune suppression and constructs a prognostic model in lung adenocarcinoma |
| title_sort | multi omics analysis reveals glutathione metabolism related immune suppression and constructs a prognostic model in lung adenocarcinoma |
| topic | multi-omics single-cell sequencing glutathione metabolism immunotherapy prognostic model |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1608407/full |
| work_keys_str_mv | AT yuxiangchi multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT yuxiangchi multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT guoyuanma multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT qiangliu multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT qiangliu multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT yunzhixiang multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT yunzhixiang multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT defengliu multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT jiajundu multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma AT jiajundu multiomicsanalysisrevealsglutathionemetabolismrelatedimmunesuppressionandconstructsaprognosticmodelinlungadenocarcinoma |